Significance of Reactive Oxygen Intermediates in Fas-mediated apoptosis.
Significance of Reactive Oxygen Intermediates in Fas-mediated apoptosis.
批准号:
08670862
负责人:
KASAHARA Yoshihito
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1) The involvement of reactive oxygen intermediates in Fas-mediated apoptosis was investigated using cells from patients with chronic granulomatous disease (CGD) that have no ability of reactive oxygen intermediates production. Although the treatments with anti-Fas antibody induced apoptosis of cells from normal subjects, cells from CGD were resistant to anti-Fas antibody. Catalase significantly inhibited Fas-mediated apoptosis of normal cells, on the other hands hydrogen peroxides induced apoptosis of CGD cells.2) Fas-mediated apoptosis was estimated in two siblings with autoimmune lymphoproliferative syndrome characterized with hepatosplenomegaly, lymphadenopathy, pancytopenia, hyper-gammagloblinemia, which is similar to clinicalmanifestations of lpr or gld mouse that have mutations of Fas or Fas ligand gene. Cells from two patients showed reduced Fas-induced apoptosis and smaller abnormal Fas protein was detected by western blot analysis. The T to C point mutation of intron 7 in patients Fas gene was detected and Fas antigen of patients lacks intracellular portion including death domain by this mutation TCRalphabeta+CD4-CD6- T cells were increased in blood I patients and analysis of family showed that mother has a same Fas mutation. These results indicated significance of Fas-mediated apoptosis in immunological homeostasis n vivo.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Kanegane, Y.Kasahara, Y.Niida, A.Yachie, S.Sugii, K.Takatsu, N.Taniguchi, and T.Miyawaki: "Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine producing populations among human memory CD4^+ T cells" Immunology. 87. 186-190 (1996)
H.Kanegane、Y.Kasahara、Y.Niida、A.Yachie、S.Sugii、K.Takatsu、N.Taniguchi 和 T.Miyawaki:“L-选择素 (CD62L) 的表达可区分 Th1 和 Th2 样细胞因子
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Kasahara, T.Wada, Y.Niida, K.Ohta, H.Seki, T.Hashimoto, T.Miyawaki, S.Koizumi, N.Taniguchi.: "Novel Fas (CD95/APO-1) mutations in infants with lymphoproliferative disorders." Int.Immunol.10 (2). 195-202 (1998)
Y.Kasahara、T.Wada、Y.Niida、K.Ohta、H.Seki、T.Hashimoto、T.Miyawaki、S.Koizumi、N.Taniguchi.:“婴儿中的新型 Fas (CD95/APO-1) 突变
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Kasahara et al: "Novel Fas(CD95/APO-1)mutations in infants with a lymphoprollferative disorder" Int.Immunol.10(2). 195-202 (1998)
Y.Kasahara 等人:“淋巴组织增生性疾病婴儿中的新型 Fas(CD95/APO-1) 突变”Int.Immunol.10(2)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
東馬 智子, 笠原 善仁, 他: "アレルギー疾患にみられる好塩基球IgE結合状態のフローサイトメトリー法による評価." アレルギー. 45(7). 627-636 (1996)
Tomoko Touma、Yoshihito Kasahara 等人:“通过流式细胞术评估过敏性疾病中的嗜碱性粒细胞 IgE 结合状态”45(7) (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Tohma, Y.Kasahara et al.: "Flowcytometric estimation of IgE binding on blood basophils in patients with allergic diseases (in Japanese)" Allergy. 45 (7). 627-636 (1996)
T.Tohma、Y.Kasahara 等人:“过敏性疾病患者血液嗜碱性粒细胞上 IgE 结合的流式细胞术评估(日语)” 过敏。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
The role of CD95-induced apoptosis system in the maturation and differentiation stages of self-antigen specific B cells
-
批准号:21591352
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:KASAHARA Yoshihito
-
依托单位:
Role of CD95-induced apoptotic system in double negative regulatory T cells
-
批准号:19591243
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KASAHARA Yoshihito
-
依托单位:
Significance of CD244 expression in functional development of CD8+ cytotoxic T lymphocytes
-
批准号:16591013
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2004
-
负责人:KASAHARA Yoshihito
-
依托单位:
Biological analysis of Fas- or Fas ligand gene mutations and basic analysis of gene therapy
-
批准号:10670710
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:KASAHARA Yoshihito
-
依托单位:
海外基金